arrow
J

Jesse K. McKenney

Glickman Urological Institute
H指数:72
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology

Gleason评分组1级前列腺癌伴最终病理pT3a病变患者的长期肿瘤学结局

2026-07-170
OAAI
Primary Ewing Sarcoma of the Kidney

肾原发性尤因肉瘤:包括罕见EWSR1::ETV4融合的24例患者临床病理及分子学研究

2025-10-010
PRE
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'

回复:“前列腺癌伴有良好组织学特征不等同于前列腺癌惰性发展”

2025-10-010
OA
Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancer

破坏雄激素受体与其共调节因子WDR77之间的相互作用会延缓治疗抵抗性前列腺癌的生长

2025-09-090
OAAI
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies

前列腺腺癌根据组织学形态分为有/无利组织学分类在前列腺针芯活检中具有高度的可重复性。

2025-08-050
OAAI
Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists
2024-09-170
OAAI
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer

使用方案指导的前列腺癌主动监测的患者的长期结果

2024-06-255
OA
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage
2024-06-033
PRE
Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK-RAS Pathway

肾小球细胞瘤的分子特征: mapk-ras通路改变的证据

2024-06-012
PRE
Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer
2024-03-220
PRE
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
2024-01-044
OAAI